The two companies will invest as partners in global medtech enterprises with the goal of accelerating their market entry and commercialization in China.
January 8, 2017 -- Ally Bridge Group, a Hong Kong-based life science investor, entered into a strategic partnership with Lifetech Scientific to invest in global medical device companies. LifeTech is a Shenzhen medical device maker. The two companies will invest as partners in global medtech enterprises with the goal of accelerating their market entry and commercialization in China. ABG and its affiliates manage $1.5 billion in healthcare assets in China, the US and Europe, from medtech to biopharmaceuticals.
